Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...
Please provide your email address to receive an email when new articles are posted on . Conjugated estrogen/bazedoxifene users had higher endometrial cancer and endometrial hyperplasia rates vs.
The impact of tumor molecular profile-directed treatment on survival in recurrent ovarian cancer. This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This abstract does not include a ...
Reproductive and Sexual Function After Platinum-Based Chemotherapy in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study This multicenter prospective study was carried out ...
Cancer therapy has improved significantly in recent years, and the concept of care has changed as well. Whereas in the past, cancer therapy was radical and definite, now new, more conservative ...
Uterine cancer is the fourth most common cancer among women and the most common cancer of a woman's reproductive system. There are two major types of uterine cancer: Adenocarcinoma of the endometrium: ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Bayer AG is launching a new clinical ...
Hormonal therapy with an intrauterine device (IUD) led to complete tumor regression in two-thirds of women with early-stage endometrial cancer or precancerous lesions, a randomized pragmatic phase II ...
Despite affecting 1 in 10 women during their fertile years, and notwithstanding recent public awareness campaigns, endometriosis may not receive the attention it deserves. Often, symptoms are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback